Compared to classical NF-κB, far less studies have been published on the alternative pathway, even though the pinnacle kinase of this signaling arm, NIK, is activated in multiple cancer types, including multiple myeloma, carcinomas (pancreas, ovarian and lung) and melanoma [15, 16]. The gene discussed is NFKB1; the disease is plasma cell myeloma.